Back to Top Skip to main content

DoD adds fentanyl to drug testing panel

An Airman from the 436th Air Wing inspects a bottle before being asked to provide a urine sample November 8, 2019. The DoD has a zero tolerance policy for the illegal or improper use of drugs by service members. (U.S. Air Force photo by Staff Sgt. Nicole Leidholm) An Airman from the 436th Air Wing inspects a bottle before being asked to provide a urine sample November 8, 2019. The DoD has a zero tolerance policy for the illegal or improper use of drugs by service members. (U.S. Air Force photo by Staff Sgt. Nicole Leidholm)

Recommended Content:

Armed Forces Medical Examiner System | Substance Abuse

DOVER AIR FORCE BASE, Del. — The Department of Defense implemented new policy in March 2019 to direct all service Drug Demand Reduction Program labs to test for fentanyl and norfentanyl.

The DoD has a zero tolerance policy for the illegal or improper use of drugs by service members. Because of this, all U.S. service members are subject to random urinalysis testing.

When trends start to be seen in society, the DoD looks at the potency and lethality of the drug, before being considered for additional testing on the panel, said Navy Capt. Eric R. Welsh, Office of Drug Demand Reduction director.

Fentanyl is an opioid, similar to heroin. It is 50 times more potent than heroin and 100 times more potent than morphine.

“Fentanyl and its metabolite, norfentanyl, have garnered national attention lately because of fentanyl’s growing popularity and potential lethality,” said Navy Lt. Cmdr. Katherine Dozier, Armed Forces Medical Examiner System Special Forensic Toxicology Drug Testing Laboratory chief. “This, combined with the emergence of fentanyl and norfentanyl in SFTDTL’s DoD surveillance testing, led the Office of Drug Demand Reduction to petition for fentanyl’s addition to the standard DDRP drug testing panel.”

The five service branch DDRPs and the AFMES SFTDTL began fentanyl screening in June 2019.

“Very small quantities of fentanyl can have significant effects,” said Dozier. “The illicit drug trade is aware of this, and has used fentanyl to cheaply adulterate heroin, cocaine, and other illicit drugs to enhance effects.”

The SFDTL at AFMES provides surveillance testing for the DoD, as well as civilian populations through approved collaborations.

“The SFDTL determines current drug trends and confirmation testing for the five service DDRP labs,” said Dozier. “We confirm fentanyl and its metabolite, norfentanyl, as well as synthetic cannabinoids, commonly called Spice or K2.”

According to the National Institute of Drug Abuse, Spice and K2 are often called marijuana or “fake weed” because some of its chemicals are like those in marijuana, however, the effects can be unpredictable and in some cases, severe or even life-threatening.

“Robust, frequent and random drug testing of our personnel is one of our greatest weapons against drug use,” said Welsh. “Even though the Department tests for more drugs than ever before, the positive rate was the lowest observed in 20 years at 0.84 percent.”

According to DoD instruction 1010.16, drug testing is used to permit commanders to assess the security, military fitness, readiness, good order and discipline of their commands and allow commanders to take disciplinary or administrative action as appropriate.

“Illicit drug use by service members is a national security threat and a health and safety concern,” said Dozier. “Many of these drugs have been shown to affect decision-making, risk-taking, and levels of consciousness. For the well-being of every service member and every U.S. citizen they defend, illicit drug use in the military must be taken seriously.”

When a service member is asked to submit a urine sample for testing, it is done at their location’s DDRP. The sample is then shipped to the one of the five service branch FTDTLs, where it is tested via immunoassay, the same scientific technique used in pregnancy tests that allows for an answer of either negative or presumptive positive.

“If a specimen tests presumptively positive on the immunoassay for synthetic cannabinoids or fentanyl, it is sent to SFTDTL for confirmation,” said Dozier. “We confirm these specimens using Liquid Chromatography Tandem Mass Spectrometry.”

The spectrometer is able to positively identify and measure the amount of fentanyl or norfentanyl in urine specimens, which leads to a positive result reported.

“If there is a positive result for a prescription drug, such as fentanyl, the result will be forwarded to the medical review officer to determine if the use of the prescription is legitimate,” said Pamela Iseminger, 436th Air Wing DDRP manager. “If there is no medical documentation in the members file to substantiate the positive test, the unit commander will meet with the member to provide written notice of the positive result.”

Then, the member is provided 30 calendar days to produce any medical records or other documentation which may justify the positive result, said Iseminger.

“The DDRP directly impacts mission readiness,” said Iseminger. “It acts as the focal point for installation level drug urinalysis testing and drug prevention programs and ensures a work place free of illicit drugs use and provides a mission-ready fighting force at all times.”

Disclaimer: Re-published content may be edited for length and clarity.  Read original post.

 

You also may be interested in...

To drink, or not to drink

Article
11/9/2018
If you are battling substance abuse, consider attending an alcohol-free holiday party or host your own alcohol-free small gathering

If you are battling substance abuse, consider attending an alcohol-free holiday party or host your own alcohol-free small gathering

Recommended Content:

Substance Abuse

AFMES participates in 'Safe and Sound' week

Article
8/27/2018
Air Force Tech Sgt. Aisuluu Alford (left) and Army Staff Sgt. Joseph Tutt, both Armed Forces Medical Examiner System forensic toxicology laboratory technicians, grab supplies out of the Shelter-In-Place Kit during a Shelter-In-Place exercise. The exercise was part of Safe and Sound week where AFMES personnel were able to engage in different safety activities. (U.S. Air Force photo by Staff Sgt. Nicole Leidholm)

Safe and Sound Week is a nationwide campaign to raise awareness and understanding of safety and health programs within the workplace

Recommended Content:

Armed Forces Medical Examiner System | Office of the Armed Forces Medical Examiner

AFMES DoD DNA Operations Fact Sheet 2018

Fact Sheet
8/22/2018

This Fact Sheet describes the purpose of the Armed Forces Medical Examiner System's Department of Defense DNA Operations

Recommended Content:

Armed Forces Medical Examiner System | Office of the Armed Forces Medical Examiner | DoD DNA Operations | DNA Identification Laboratory

AFMES DoD DNA Lab receives perfect score

Article
8/6/2018
Sean Patterson, quality management section DNA analyst, checks expiration dates on reagents in the Armed Forces Medical Examiner System – Armed Forces DNA Identification Laboratory. AFDIL recently underwent a quality assessment where they received zero findings of nonconformance for the first time. (U.S. Air Force photo by Staff Sgt. Nicole Leidholm)

This was the first time AFDIL has received zero findings during a quality assessment

Recommended Content:

Armed Forces Medical Examiner System

Drug-monitoring innovations help providers help their patients

Article
8/6/2018
Two Military Health System innovations are helping to ensure best practices for patients with pain, and for patients who’ve been diagnosed with post-traumatic stress disorder. (U.S. Air Force photo by Senior Airman Curt Beach)

Focus is on management of pain and PTSD

Recommended Content:

Innovation | Substance Abuse | Posttraumatic Stress Disorder | Pain Management | Opioid Safety

DHA PI 6490.02: Behavioral Health (BH) Treatment and Outcomes Monitoring

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (k): a. Establishes the Defense Health Agency’s (DHA) procedures for the collection and analysis of BH outcome data. b. Addresses how DoD will standardize BH outcome data collection to: assess variations in mental health and substance use care among in-garrison medical treatment facilities (MTFs) and clinics; assess the relationship of treatment protocols and practices to BH outcomes; and identify barriers to provider implementation of evidence-based clinical guidance approved by DoD. c. Designates the Army as the DoD lead Service for maintenance and sustainment of the Behavioral Health Data Portal (BHDP) in specialty care mental health and substance use clinics, referred to collectively as BH clinics, until BHDP functionality can be integrated with GENESIS or another electronic health record (EHR) system managed by DHA. d. Designates DHA Information Operations (J-6) as lead on transitioning BHDP functional requirements related to outcomes monitoring to future EHR data collection platforms and processes.

There is hope

Article
7/12/2018
Medically assisted treatment for opioid use can break the cycle of addiction.

More than 350,000 deaths are attributed to opioid overdoses nationwide since 1999

Recommended Content:

Mental Health Care | Substance Abuse | Addiction | Mental Wellness | Opioid Safety

AFMES embraces resiliency

Article
7/9/2018
Col. Louis Finelli, the Armed Forces Medical Examiner System director, talks with AFMES personnel during a resiliency day at Dover International Speedway, Dover, Del., May 24, 2018. Finelli talked about the importance of coming together as a family to be able to destress and be more resilient. (U.S. Air Force photo by Staff Sgt. Nicole Leidholm)

AFMES town hall focused on workplace and summer safety, security awareness and resiliency

Recommended Content:

Armed Forces Medical Examiner System | Office of the Armed Forces Medical Examiner

Life without liquor

Article
6/29/2018
There are 2.5 million alcohol-related deaths worldwide each year, according to the National Council on Alcoholism and Drug Dependence. (Courtesy photo)

One service member’s story of how he overcame a drinking problem

Recommended Content:

Mental Wellness | Substance Abuse

AFMES DNA FAQs 2018

Fact Sheet
6/27/2018

This Fact Sheet describes the purpose of the Armed Forces Medical Examiner System's Armed Forces DNA Identification Laboratory.

Recommended Content:

Armed Forces Medical Examiner System | Office of the Armed Forces Medical Examiner | DoD DNA Operations | DNA Identification Laboratory

Progress in preventing opioid abuse, more needs to be done

Article
6/26/2018
Air Force Staff Sgt. Matthew Pick, with the 66th Security Forces Squadron, holds a nasal applicator and naloxone medication vial at Hanscom Air Force Base, Massachusetts. Naloxone is one of several medications designed to temporarily reverse the effects of an opioid overdose. Hanscom was the first Air Force installation to issue the drug to law enforcement personnel under permission of the base commander. (U.S. Air Force photo by Mark Herlihy)

The Military Health System has a shared responsibility in addressing the nation’s opioid epidemic

Recommended Content:

Substance Abuse | Pain Management | Opioid Safety

DHA PI 6025.04: Pain Management and Opioid Safety in the MHS

Policy

The purpose of our MHS Pain Management Campaign is to enable Clinical Communities to provide evidence-based pain management guided by clinical practice guidelines (CPGs): effectively treat acute and chronic pain; promote non-pharmacologic treatment; prevent acute pain from becoming chronic; and minimize use of opioids with appropriate prescribing only when indicated. The Pain Management Clinical Support Service achieves these ends through clinical improvements in pain care, clinician and patient education, and research. This Defense Health Agency-Procedural Instruction (DHA-PI) is a dual effort between the Pain Management Clinical Support Service and the Clinical Communities to achieve our stated purpose through implementation of the MHS Stepped Care Model.

AFMES Fact Sheet 2018

Fact Sheet
6/7/2018

This Fact Sheet describes the purpose of the Armed Forces Medical Examiner System.

Recommended Content:

Armed Forces Medical Examiner System | Office of the Armed Forces Medical Examiner | DoD DNA Operations | Forensic Toxicology

AFMES DNA lab helps identify the fallen of past conflicts

Article
5/30/2018
Gina Parada, Armed Forces Medical Examiner System DNA analyst, collects a DNA sample during a POW/MIA Accounting Agency Family Member Update in Louisville, Kentucky. DNA can be used to support anthropology of recovered skeletal remains or be used as primary means of identification. (U.S. Air Force photo by Tech. Sgt. Robert M. Trujillo)

DNA can be used to support anthropology of recovered skeletal remains or be used as primary means of identification

Recommended Content:

Office of the Armed Forces Medical Examiner | Armed Forces Medical Examiner System

AFMES participates in Operation Joint Recovery, introduces MACRMS

Article
3/20/2018
U.S. Navy Lt. Cmdr. Bryan Platt (right), Armed Forces Medical Examiner System forensic pathologist, demonstrates an examination at a simulated Mortuary Affairs Contaminated Remains Mitigation Site during Operation Joint Recovery exercise at Joint Base McGuire-Dix-Lakehurst, N.J., Mar. 10, 2018. Platt familiarized participants in recovery and processing of contaminated remains. (U.S. Air Force photo by Tech. Sgt. Robert M. Trujillo)

AFMES primary role in the exercise was to familiarize participants in contaminated remains recovery

Recommended Content:

Armed Forces Medical Examiner System
<< < 1 2 3 > >> 
Showing results 16 - 30 Page 2 of 3

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.